Logo image
Genomics, microbiomics, proteomics, and Chock for metabolomics in bronchopulmonary dysplasia
Journal article   Open access   Peer reviewed

Genomics, microbiomics, proteomics, and Chock for metabolomics in bronchopulmonary dysplasia

Charitharth Vivek Lal, Vineet Bhandari and Namasivayam Ambalavanan
Seminars in perinatology, v 42(7), pp 425-431
01 Nov 2018
PMID: 30487069
url
https://doi.org/10.1053/j.semperi.2018.09.004View
Published, Version of Record (VoR)CC BY-NC-ND V4.0 Open

Abstract

Life Sciences & Biomedicine Obstetrics & Gynecology Pediatrics Science & Technology
Bronchopulmonary Dysplasia (BPD) is a disorder with a multifactorial etiology and highly variable clinical phenotype. Several traditional biomarkers have been identified, but due to the complex disease phenotype, these biomarkers have low predictive accuracy for BPD. In recent years, newer technologies have facilitated the in-depth and unbiased analysis of 'big data' in delineating the diagnosis, pathogenesis, and mechanisms of diseases. Novel systems-biology based 'omic' approaches, including but not limited to genomics, microbiomics, proteomics, and metabolomics may help define the multiple cellular and humoral interactions that regulate normal as well as abnormal lung development and response to injury that are the hallmarks of BPD. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Metrics

6 Record Views
53 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Obstetrics & Gynecology
Pediatrics
Logo image